{
  "compound": "Cannabis and cannabinoids",
  "condition": "PARKINSONS",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:PD_GUIDELINE_001",
  "participants": "Evidence-based guideline review",
  "year": 2020,
  "notes": "MDS Evidence-Based Review: Complementary Therapies in Parkinson's Disease",
  "confidence": "medium",
  "abstract": "Classification: Insufficient evidence to recommend for motor symptoms; Possibly useful for non-motor symptoms (sleep, pain, QoL); More research needed"
}